Interdisciplinarity
By Jonathan Kahn, Biopolitical Times guest contributor
| 01. 24. 2011
In 2009, the director of the National Science Foundation gave a key note
address at an interdisciplinary conference on synthetic biology
sponsored by the National Academies. The director opened with the
following joke:
“A synthetic biologist and a social scientist await death
at the hands of an executioner. The executioner asks the social
scientist if he has a final wish. Yes, he says, I have some new findings
on the societal and ethical dimensions of synthetic biology and I want
to present them to the scientific community before I die. The
executioner then turns to the synthetic biologist and asks if she has a
final wish. Yes, she said, just shoot me before I have to listen to that
lecture.”
It’s a good joke. I have sat through many lectures over the years
that make me sympathize with the synthetic biologist. Lest he offend
anyone in the audience, the director quickly followed the joke with a
disclaimer that certainly no one in the present audience harbored such
sentiments. Nonetheless, the joke is instructive on several levels.
Synthetic
biology is merely...
Related Articles
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...